Detalles de la búsqueda
1.
A higher non-severe hypoglycaemia rate is associated with an increased risk of subsequent severe hypoglycaemia and major adverse cardiovascular events in individuals with type 2 diabetes in the LEADER study.
Diabetologia
; 65(1): 55-64, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34704120
2.
Body weight loss with oral semaglutide is mediated predominantly by effects other than gastrointestinal adverse events in patients with type 2 diabetes: A post hoc analysis.
Diabetes Obes Metab
; 25(4): 1130-1135, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36562481
3.
Impact of kidney function on the safety and efficacy of insulin degludec versus insulin glargine U300 in people with type 2 diabetes: A post hoc analysis of the CONCLUDE trial.
Diabetes Obes Metab
; 24(2): 332-336, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34605127
4.
Hospitalization costs with degludec versus glargine U100 for patients with type 2 diabetes at high cardiovascular risk: Canadian costs applied to SAEs from a randomized outcomes trial.
J Med Econ
; 24(1): 1318-1326, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34763587
5.
Commentary to "Differential Effect of Hypoalbuminemia on Hypoglycemia on Type 2 Diabetes Patients Treated with Insulin Glargine 300 U/ml and Insulin Degludec" by Kawaguchi et al. Diabetes Therapy 2019.
Diabetes Ther
; 11(2): 561-567, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31925723
Resultados
1 -
5
de 5
1
Próxima >
>>